Implementation, process, and outcomes of nutrition best practices for infants <1500 g

Nutr Clin Pract. 2011 Oct;26(5):614-24. doi: 10.1177/0884533611418984.

Abstract

Background: Extrauterine growth restriction (EUGR; weight ≤10th percentile) affects many infants ≤1500 g birth weight (BW). EUGR is associated with poor neurodevelopmental outcomes. The objective of this study was to evaluate the impact of optimizing nutrition administration in infants ≤1500 g.

Methods: A retrospective chart review compared infants ≤1500 g before (n = 32) and after (n = 49) implementation of nutrition practice changes designed to decrease EUGR. Changes included early aggressive parenteral nutrition (PN), early enteral feedings, trophic feedings, continuous feeding administration, protein fortification of 24-cal/oz mother's own breast milk, and development of a "feeding intolerance" algorithm. The authors evaluated demographics, growth parameters, secondary feeding, and discharge outcomes. Differences in subgroups of infants ≤1000 g and 1000-1500 g BW were assessed.

Results: Implementation of the nutrition practice changes decreased EUGR as defined by weight ≤10th percentile at discharge from 57% in the preimplementation group to 28% in the postimplementation group (P = .01). Weight percentile ranking at 36 weeks' gestational age increased significantly in infants 1001-1500 g, from the 13th to the 27th percentile (P = .004 and P = .01, respectively). Chronic lung disease decreased significantly (P = .02). There was no increase in necrotizing enterocolitis (6% pre vs 3% post) or in blood urea nitrogen. Days of PN and central line use were decreased (P = .02 and P = .07, respectively).

Conclusions: Clearly defined changes in nutrition for infants ≤1500 g significantly improved growth outcomes without increasing undesired outcomes.

Publication types

  • Evaluation Study

MeSH terms

  • Algorithms
  • Body Weight
  • Dietary Proteins / administration & dosage
  • Enterocolitis, Necrotizing
  • Feeding Behavior
  • Female
  • Gestational Age
  • Growth Disorders / complications
  • Growth Disorders / therapy*
  • Humans
  • Infant, Newborn
  • Infant, Premature / growth & development*
  • Infant, Premature, Diseases / therapy*
  • Infant, Very Low Birth Weight / growth & development*
  • Lung Diseases / prevention & control
  • Male
  • Milk, Human
  • Nutritional Support*
  • Practice Guidelines as Topic
  • Retrospective Studies

Substances

  • Dietary Proteins